Covid-19 Diagnostics Market
Market Insights on Covid-19 Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Covid-19 Diagnostics Market by Product Type (Instruments, Test Kits, Reagents and Consumables), Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine), Technology (PCR, ELISA, POC), End User & Region - Forecast to 2020 - 2030
Covid-19 Diagnostics Market Outlook and Findings
- [280 Pages Report] The Covid-19 diagnostics market players look to develop highly sensitive and specific testing kits
- RT-PCR remains the most widely used diagnostic test globally
- Leading players boosting production by launching automated COVID-19 testing systems
- Springing up of local players to combat Covid-19 providing a competitive edge to the market
Let us know your requirement to get
100% FREE customization
Covid-19: A Snapshot
As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.
The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.
By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.
The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.
Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.
Key Market Trends
RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.
As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.
Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020-2030).
For instance –
- In Jul 2020, Avacta announced beginning of clinical validation of high throughput Covid-19 laboratory test (Adeptrix Covid-19 diagnostic test) by collaborating with CONDOR program by the government of UK
- In Jul 2020, BATM launched 3 novel diagnostic kits, namely – Covid-19 serologic test, Covid-19 antigen test, and new molecular diagnostics test for advancing Covid-19’s diagnosis
- In July 2020, Mylab launched “Compact XL”, a machine for automating all the manual processes of molecular diagnostic tests, inclusive of Covid-19’s RT-PCR tests
- In Jul 2020, The National Institute of Health selected the rapid Covid-19 test under the Rapid Acceleration of Diagnostics Tech (RADx Tech) program. Researchers at MIT, along with 3M have started with an accelerated research to check if a simple device could produce accurate results and its feasibility regarding mass production
- In Jul 2020, Quest Diagnostics received authorization from the US FDA regarding laboratory technique to be employed in Covid-19 diagnostic testing
- In June 2020, T2 Biosystems, Inc. announced that it had finished with validation of Covid-19 molecular diagnostic test – the “T2SARS-CoV-2 Panel” under license agreement with Hackensack Meridian Health’s Center of Discovery and Innovation. Distribution at the commercial level has been permitted after having met requirements for an EUA (Emergency Use Authorization) request to the US FDA
- In Jun 2020, Mobidiag received CE-IVD markings relating to the two tests enabling reliable and rapid detection of Covid-19. They are – Amplidiag Covid-19 for catering to large laboratories for batch volume tests and Novodiag Covid-19 for on-demand, single tests
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystResearch and Offbeat Discoveries to Drive the Market
Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.
For instance –
- In Jul 2020, AdvaMed announced creation of an exhaustive national Covid-19 diagnostic supply registry for lending a helping hand to federal and state pandemic responses.
- In Jul 2020, The Journal of the American Osteopathic Association published a research paper that stated that obtaining eosinophil count also helps in detection of Covid-19. It also presented that out of Covid-19 patients, 60% did have zero eosinophils at presentation. The once not affected had not more than 16%.
- India-based IIT Delhi, in Jul 2020, launched “Corosure”, the Covid-19 test kit at a base price of US $5 only.
- In Jul 2020, SRL Diagnostics, in collaboration with Fortis Hospital, decided to launch antigen test facility to diagnose Covid-19 in Karnataka, India.
Players to fill the Void for asymptomatic Patients
Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.
To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.
On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.
Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.
Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Covid-19 Diagnostics Market: Regional Analysis
The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.
Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.
Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market
Major Players in the Covid-19 Diagnostics Market
The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.
Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.
Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.
The other major players include:
- Veredus Laboratories
- Thermo Fisher Scientific, Inc.
- Quidel Corporation
- Perkin Elmer, Inc.
- Neuberg Diagnostics
- Mylab Discovery Solutions Pvt Ltd.
- Luminex Corporation
- Laboratory Corporation of America Holdings
- Hologic Inc.
- Danaher
- Cepheid
- bioMérieux SA
- Altona Diagnostics GmbH
- ALDATU BIOSCIENCES
- ADT Biotech Sdn Bhd
- Abbott
- 1drop Inc.
Covid-19 Diagnostics market: The Way Forward
The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.
The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.
Key Segment
Product Type
- Instruments
- Test Kits
- Reagents and Consumables
Sample Type
- Oropharyngeal & Nasopharyngeal Swabs
- Blood
- Urine
- Others
Technology
- PCR
- ELISA
- POC
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.
The covid-19 diagnostics market size is estimated to cross US$ 204.51 Bn by 2032.
The covid-19 diagnostics market is likely to record a value of US$ 97.4 Bn in 2022.
Europe is likely to lead the covid-19 diagnostics market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Technology Adoption / Usage Analysis
4.2. Key Product Features and their USPs
4.3. Key Promotional Strategies, By Manufacturers
4.4. Regulations, By Region
5. Global COVID-19 Diagnostics Market (Volume in Units) Analysis 2015-2019 and Forecast, 2020-2030
5.1. Historical Market Volume (in Units) Analysis, 2015-2019
5.2. Current and Future Market Volume (in Units) Projections, 2020-2030
6. Global COVID-19 Diagnostics Market - Pricing Analysis
6.1. Average Pricing Analysis By Region
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global COVID-19 Diagnostics Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Per Capita Healthcare Expenditure Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Increase in R&D Funding and Grants
8.2.2. Increase in Number of Corona Virus Disease Cases
8.2.3. Diagnosis Seeking Rate
8.2.4. COVID-19 Disease Mortality Rate
8.2.5. Industry Consolidation to Increase Capacity
8.2.6. Increase in Manufacturing Activity
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
8.4. COVID19 Crisis Analysis
8.4.1. Current COVID19 Statistics and Probable Future Impact
8.4.2. Current GDP Projection and Probable Impact
8.4.3. Current Economic Projection as compared to 2008 Economic analysis
8.4.4. COVID19 and Impact Analysis
8.4.4.1. Revenue By Product Type
8.4.4.2. Revenue By Sample Type
8.4.4.3. Revenue By Technology
8.4.4.4. Revenue By End User
8.4.4.5. Revenue By Country
8.4.5. 2020 Market Scenario
8.4.6. Quarter by Quarter Forecast
8.4.7. Projected recovery Quarter
8.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
9. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019
9.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2020-2030
9.3.1. Instruments
9.3.2. Test Kits
9.3.2.1. Rapid Test Kits
9.3.2.2. Assay Based Test Kits
9.3.3. Reagents and Consumables
9.4. Market Attractiveness Analysis By Product Type
10. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Sample Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Sample Type, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2020-2030
10.3.1. Oropharyngeal & Nasopharyngeal Swabs
10.3.2. Blood
10.3.3. Urine
10.3.4. Others
10.4. Market Attractiveness Analysis By Sample Type
11. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Technology
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030
11.3.1. PCR
11.3.2. ELISA
11.3.3. POC
11.4. Market Attractiveness Analysis By Technology
12. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
12.3.1. Hospitals
12.3.2. Speciality Clinics
12.3.3. Diagnostic Centers
12.3.4. Pathology Laboratories
12.3.5. Research Institutes
12.4. Market Attractiveness Analysis By End User
13. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) & Volume Analysis By Region, 2015 - 2019
13.3. Current Market Size (US$ Mn) & Volume Analysis and Forecast By Region, 2020 - 2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product Type
14.3.3. By Sample Type
14.3.4. By Technology
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product Type
15.3.3. By Sample Type
15.3.4. By Technology
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product Type
16.3.3. By Sample Type
16.3.4. By Technology
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Sample Type
17.3.4. By Technology
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product Type
18.3.3. By Sample Type
18.3.4. By Technology
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
19.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product Type
19.3.3. By Sample Type
19.3.4. By Technology
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019
20.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Product Type
20.3.3. By Sample Type
20.3.4. By Technology
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key and Emerging Countries COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. COVID-19 Diagnostics Market Analysis
21.2.1. By Product Type
21.2.2. By Sample Type
21.2.3. By Technology
21.2.4. By End User
21.3. Canada COVID-19 Diagnostics Market Analysis
21.3.1. By Product Type
21.3.2. By Sample Type
21.3.3. By Technology
21.3.4. By End User
21.4. Mexico COVID-19 Diagnostics Market Analysis
21.4.1. By Product Type
21.4.2. By Sample Type
21.4.3. By Technology
21.4.4. By End User
21.5. Brazil COVID-19 Diagnostics Market Analysis
21.5.1. By Product Type
21.5.2. By Sample Type
21.5.3. By Technology
21.5.4. By End User
21.6. U.K. COVID-19 Diagnostics Market Analysis
21.6.1. By Product Type
21.6.2. By Sample Type
21.6.3. By Technology
21.6.4. By End User
21.7. Germany COVID-19 Diagnostics Market Analysis
21.7.1. By Product Type
21.7.2. By Sample Type
21.7.3. By Technology
21.7.4. By End User
21.8. France COVID-19 Diagnostics Market Analysis
21.8.1. By Product Type
21.8.2. By Sample Type
21.8.3. By Technology
21.8.4. By End User
21.9. Italy COVID-19 Diagnostics Market Analysis
21.9.1. By Product Type
21.9.2. By Sample Type
21.9.3. By Technology
21.9.4. By End User
21.10. Spain COVID-19 Diagnostics Market Analysis
21.10.1. By Product Type
21.10.2. By Sample Type
21.10.3. By Technology
21.10.4. By End User
21.11. BENELUX COVID-19 Diagnostics Market Analysis
21.11.1. By Product Type
21.11.2. By Sample Type
21.11.3. By Technology
21.11.4. By End User
21.12. Russia COVID-19 Diagnostics Market Analysis
21.12.1. By Product Type
21.12.2. By Sample Type
21.12.3. By Technology
21.12.4. By End User
21.13. China COVID-19 Diagnostics Market Analysis
21.13.1. By Product Type
21.13.2. By Sample Type
21.13.3. By Technology
21.13.4. By End User
21.14. Japan COVID-19 Diagnostics Market Analysis
21.14.1. By Product Type
21.14.2. By Sample Type
21.14.3. By Technology
21.14.4. By End User
21.15. South Korea COVID-19 Diagnostics Market Analysis
21.15.1. By Product Type
21.15.2. By Sample Type
21.15.3. By Technology
21.15.4. By End User
21.16. India COVID-19 Diagnostics Market Analysis
21.16.1. By Product Type
21.16.2. By Sample Type
21.16.3. By Technology
21.16.4. By End User
21.17. ASEAN COVID-19 Diagnostics Market Analysis
21.17.1. By Product Type
21.17.2. By Sample Type
21.17.3. By Technology
21.17.4. By End User
21.18. Australia COVID-19 Diagnostics Market Analysis
21.18.1. By Product Type
21.18.2. By Sample Type
21.18.3. By Technology
21.18.4. By End User
21.19. New Zealand COVID-19 Diagnostics Market Analysis
21.19.1. By Product Type
21.19.2. By Sample Type
21.19.3. By Technology
21.19.4. By End User
21.20. GCC Countries COVID-19 Diagnostics Market Analysis
21.20.1. By Product Type
21.20.2. By Sample Type
21.20.3. By Technology
21.20.4. By End User
21.21. Turkey COVID-19 Diagnostics Market Analysis
21.21.1. By Product Type
21.21.2. By Sample Type
21.21.3. By Technology
21.21.4. By End User
21.22. South Africa COVID-19 Diagnostics Market Analysis
21.22.1. By Product Type
21.22.2. By Sample Type
21.22.3. By Technology
21.22.4. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional footprint of Players
22.4.2. Product foot print by Players
22.4.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Thermo Fisher Scientific, Inc.
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
23.3.1.4. Sales Footprint
23.3.1.5. Strategy Overview
23.3.1.5.1. Marketing Strategy
23.3.1.5.2. Product Strategy
23.3.1.5.3. Channel Strategy
23.3.2. Danaher
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
23.3.2.4. Sales Footprint
23.3.2.5. Strategy Overview
23.3.2.5.1. Marketing Strategy
23.3.2.5.2. Product Strategy
23.3.2.5.3. Channel Strategy
23.3.3. F. Hoffman-La Roche Ltd.
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Hologic Inc.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. Laboratory Corporation of America Holdings
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Luminex Corporation
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. Mylab Discovery Solutions Pvt Ltd.
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Neuberg Diagnostics
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Perkin Elmer, Inc.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. Quest Diagnostics
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Quidel Corporation
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. Merck KGaA
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Veredus Laboratories
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. Abbott Laboratories
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 02: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Product Type
Table 03: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 04: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Sample Type
Table 05: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Technology
Table 06: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By End User
Table 07: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region
Table 08: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 09: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 10: North America COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 11: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 12: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 13: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 14: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 15: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 16: Latin America COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 17: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 18: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 19: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 20: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 21: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 22: Europe COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 23: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 24: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 25: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 26: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 27: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 28: South Asia COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 29: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 30: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 31: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 32: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 33: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 34: East Asia COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 35: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 36: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 37: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 38: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 39: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 40: Oceania COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 41: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 42: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 43: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Table 44: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 45: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type
Table 46: MEA COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 47: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type
Table 48: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology
Table 49: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis, 2015–2019
Figure 02: Global COVID-19 Diagnostics Market Volume (in '000 Unit) & Y-o-Y Growth (%) Analysis, 2020–2030
Figure 03: Global COVID-19 Diagnostics Market Value Share, By Product Type, 2019 (A)
Figure 04: Global COVID-19 Diagnostics Market Value Share, By Sample Type, 2019 (A)
Figure 05: Global COVID-19 Diagnostics Market Value Share, By Technology, 2019 (A)
Figure 06: Global COVID-19 Diagnostics Market Value Share, By End User, 2019 (A)
Figure 07: Global COVID-19 Diagnostics drugs Market Value Analysis 2015-2019 & 2020-2030
Figure 08: Global COVID-19 Diagnostics drugs Market Y-O-Y Growth Analysis By Region
Figure 09: Global COVID-19 Diagnostics Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)
Figure 10: Global COVID-19 Diagnostics Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019
Figure 11: Global COVID-19 Diagnostics Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030
Figure 12: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 13: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Product Type, 2020–2030
Figure 14: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020–2030
Figure 15: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Sample Type, 2020 & 2030
Figure 16: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Sample Type, 2020–2030
Figure 17: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020–2030
Figure 18: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Technology, 2020 & 2030
Figure 19: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Technology, 2020–2030
Figure 20: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020–2030
Figure 21: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By End User, 2020 & 2030
Figure 22: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By End User, 2020–2030
Figure 23: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020–2030
Figure 24: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Region, 2020 & 2030
Figure 25: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Region, 2020–2030
Figure 26: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Region, 2020–2030
Figure 27: North America COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 28: North America COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 29: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 30: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 31: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 32: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 33: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 34: Latin America COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 35: Latin America COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 36: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 37: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 38: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 39: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 40: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 41: Europe COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 42: Europe COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 43: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 44: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 45: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 46: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 47: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 48: South Asia COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 49: South Asia COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 50: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 51: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 52: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 53: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 54: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 55: East Asia COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 56: East Asia COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 57: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 58: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 59: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 60: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 61: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 62: Oceania COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 63: Oceania COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 64: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 65: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 66: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 67: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 68: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 69: MEA COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019
Figure 70: MEA COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030
Figure 71: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030
Figure 72: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030
Figure 73: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030
Figure 74: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030
Figure 75: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030
Figure 76: US COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 77: US COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 78: US COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 79: US COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 80: Canada COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 81: Canada COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 82: Canada COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 83: Canada COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 84: Brazil COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 85: Brazil COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 86: Brazil COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 87: Brazil COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 88: Mexico COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 89: Mexico COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 90: Mexico COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 91: Mexico COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 92: Germany COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 93: Germany COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 94: Germany COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 95: Germany COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 96: Italy COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 97: Italy COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 98: Italy COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 99: Italy COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 100: France COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 101: France COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 102: France COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 103: France COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 104: U.K. COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 105: U.K. COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 106: U.K. COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 107: U.K. COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 108: Spain COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 109: Spain COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 110: Spain COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 111: Spain COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 112: BENELUX COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 113: BENELUX COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 114: BENELUX COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 115: BENELUX COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 116: Russia COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 117: Russia COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 118: Russia COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 119: Russia COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 120: China COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 121: China COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 122: China COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 123: China COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 124: Japan COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 125: Japan COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 126: Japan COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 127: Japan COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 128: South Korea COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 129: South Korea COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 130: South Korea COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 131: South Korea COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 132: India COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 133: India COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 134: India COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 135: India COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 136: Australia COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 137: Australia COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 138: Australia COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 139: Australia COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 140: New Zealand COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 141: New Zealand COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 142: New Zealand COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 143: New Zealand COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 144: GCC Countries COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 145: GCC Countries COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 146: GCC Countries COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 147: GCC Countries COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 148: South Africa COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 149: South Africa COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 150: South Africa COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 151: South Africa COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Figure 152: Turkey COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)
Figure 153: Turkey COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)
Figure 154: Turkey COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)
Figure 155: Turkey COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
